AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SAMUELS, L. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SAMUELS, L. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

DETECTION AND LOCALIZATION OF EXTRA-SKELETAL MALIGNANT NEOPLASMS OF CHILDREN WITH STRONTIUM 87m

LARRY D. SAMUELS M.D.1

1 This paper was completed while the author was the guest of Professor J. Einhorn, Director, Radiumhemmet, Karolinska Institutet, Stockholm, Sweden.

Sr87m localizes in children’s malignant soft tissue tumors with enough specificity to allow circumscribed visualization of the neoplasms on rectilinear scans.

In a series of 10 children with chest masses, increased uptake of Sr87m was apparent in all 7 malignant tumors. There was no visible abnormal uptake in 3 benign lesions or in 10 children without pulmonary disease.

Uptake of Sr87m into malignant soft tissue tumors is a newly discovered phenomenon which appears to be independent of the visualization of bone tumors with strontium isotopes. The mechanism of this uptake into malignant soft tissue tumors does not appear to be due to differential vascularity. It may be analogous to the recently described affinity of gallium isotopes for malignant tumors.

Sr87m scans are proposed as a screening test for hidden malignancy and for the differential diagnosis and spatial visualization of masses seen on roentgenograms, thereby facilitating radiation therapy.

Further investigation and exploitation of this new cancer diagnostic agent is encouraged.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by the American Roentgen Ray Society.